COMMUNITY ANNOUNCEMENT: Huge congratulations to Neda Aghajani Memar, Pharm D!

Dear Community Members, The Iranian Cultural Society of North Carolina (ICSNC) is thrilled to share a wonderful accomplishment within our community. We are thrilled to share that the FDA has just approved the first therapy to target muscle loss in Spinal Muscular Atrophy—a groundbreaking treatment created by Neda Aghajani Memar, at Scholar Rock, where she serves as Global Senior Director of Regulatory Affairs. Remarkably, this is the third FDA approval Neda has secured during her career, including her vital work on a COVID-19 vaccine. Seeing our first-generation community members achieve such incredible heights fills us all with immense pride. We wish Neda and her proud family a wonderful time celebrating this major milestone, and we look forward to cheering her on in her future successes! You can read the details of the FDA approval here. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-therapy-target-muscle-loss-spinal-muscular-atrophy Warmly, The ICSNC Board of Directors